A PHASE 3 EFFICACY AND SAFETY STUDY OF FOSMANOGEPIX FOR THE TREATMENT OF ADULT PARTICIPANTS WITH CANDIDEMIA AND/OR INVASIVE CANDIDIASIS
Research Grant
Awarded By
Basilea Pharmaceutica International Ltd, Allschwil
Start Date
February 17, 2026
End Date
October 16, 2028
Awarded By
Basilea Pharmaceutica International Ltd, Allschwil
Start Date
February 17, 2026
End Date
October 16, 2028